ERR2598197
fetal · fetal
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- fetal
- cancer_type_detailed
- —
- subtype
- fetal
- cancer_type
- fetal
- subtype
- fetal
- sex
- fetal
- race
- fetal
- fetal_age_hindbrain
- 6
- umap1_2d
- -2.401182907
- umap2_2d
- -0.76134791
- umap1_3d
- -3.723804962
- umap2_3d
- 3.257938533
- umap3_3d
- -1.694065184
- dataset
- fetal
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- E2F_TARGETS+0.650
- G2M_CHECKPOINT+0.630
- MYC_TARGETS_V1+0.550
- WNT_BETA_CATENIN_SIGNALING+0.500
- EPITHELIAL_MESENCHYMAL_TRANSITION+0.490
- TGF_BETA_SIGNALING+0.470
- MITOTIC_SPINDLE+0.430
- ANDROGEN_RESPONSE+0.410
- UNFOLDED_PROTEIN_RESPONSE+0.390
- MYC_TARGETS_V2+0.370
Top 10 suppressed
- INTERFERON_ALPHA_RESPONSE-0.320
- OXIDATIVE_PHOSPHORYLATION-0.280
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.270
- ALLOGRAFT_REJECTION-0.230
- INTERFERON_GAMMA_RESPONSE-0.210
- COMPLEMENT-0.180
- INFLAMMATORY_RESPONSE-0.130
- IL6_JAK_STAT3_SIGNALING-0.120
- XENOBIOTIC_METABOLISM-0.120
- UV_RESPONSE_UP-0.090
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | ERR2598184 | fetal | fetal | 0.949 |
| 2 | ERR2598180 | fetal | fetal | 0.903 |
| 3 | ERR2598170 | fetal | fetal | 0.895 |
| 4 | ERR2598171 | fetal | fetal | 0.893 |
| 5 | TCGA-60-2703-01A-11R-2045-07 | — | cohortSQ1 | 0.878 |
| 6 | ERR2598185 | fetal | fetal | 0.876 |
| 7 | ERR2598166 | fetal | fetal | 0.876 |
| 8 | ERR2598169 | fetal | fetal | 0.874 |
| 9 | ERR2598181 | fetal | fetal | 0.871 |
| 10 | ERR2598207 | fetal | fetal | 0.850 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 32 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.650 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.630 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.550 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.500 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.490 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.470 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.430 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.410 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.390 | Idelalisib | — uncovered |
| MYC_TARGETS_V2 | 0.370 | Idelalisib | — uncovered |
| MTORC1_SIGNALING | 0.360 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.360 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.320 | Remibrutinib | — uncovered |
| PROTEIN_SECRETION | 0.320 | Remibrutinib | — uncovered |
| GLYCOLYSIS | 0.280 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.280 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.240 | Idelalisib | — uncovered |
| HYPOXIA | 0.240 | Idelalisib | — uncovered |
| HEME_METABOLISM | 0.230 | Temsirolimus | — uncovered |
| PANCREAS_BETA_CELLS | 0.160 | Cobimetinib | — uncovered |